*Quadrivalent influenza vaccine (surface antigen, inactivated, prepared in cell cultures)
Pharmacy owner Tanya Maloney explains why demand for Flucelvax Quad® has far exceeded her expectations. Watch the video below.
References:
- CDC. Cell-based flu vaccines. Accessed September 2022.
- Rajaram S et al. Ther Adv Vaccines Immunother. 2020;8:2515135520908121.
- Mabrouk T et al. Dev Biol (Basel). 2002;110:125–134.
- WHO. Influenza A(H3N2) lineage cell culture-derived CVVs for development and production of vaccines for use in the 2022 SH influenza season. Accessed September 2022.
- FLUCELVAX QUAD® Approved Product Information.
Seqirus (Australia) Pty Ltd Melbourne, Victoria. ABN: 66 120 398 067. ww.seqirus.com.au. Seqirus Medical Information: 1800 642 865. FLUCELVAX® is a registered trademark of Seqirus UK or its affiliates. Seqirus™ is a trademark of Seqirus UK Limited or its affiliates.
Date of preparation: April 2023. ANZ-QIVc-22-0128.





Table 1 – Types of vertigo (non-exhaustive list)[/caption]
Vomiting
In older people, dizziness significantly increases the risk of falls.7 Implementing appropriate interventions to address modifiable risk factors such as dizziness is of paramount importance. In cases of drug-induced dizziness, deprescribing can be considered if the medicine can be safely reduced, discontinued or substituted to prevent inappropriate prescribing cascades of potentially inappropriate medicines (PIM), especially in the context of older people.29










